Examining confidential wholesale margin estimates in European countries for the price negotiation of patented drugs in Germany: a statistical model.

If there is reason to believe that margins are regressive, confidential wholesale margins are expected to be better estimated by the power function based on margins of regulated countries than by the published country-specific average margins, reducing significantly inaccurate effects on margin estimations of high-price drugs.